CAS: 22788-19-8; Propylene Glycol Dilaurate
该化合物是丙烯二光酸的酯,其特征是,丙烯二光酸为乙酯,其特性为显微黄色液体,在水和有机溶剂中均以低毒性和高溶解度著称,该化合物具有乳化特性,在各种应用中,特别是在食品,化妆品和制药业中,具有实用性.该化合物作为表面活性剂,有助于稳定乳油,改善产品的质质质.此外,丙烯二光酸具有润滑剂的特性,有助于将其用于个人护理配方,在各种pH条件下和温度下,其稳定性进一步提高其在不同配方中的效用.
- 英文名称Propylene Glycol Dilaurate
- 中文名称丙二醇二月桂酸酯
- IUPAC名称propane-1,2-diyl didodecanoate
- 其它别名Propylene Glycol Dilaurate; Emalex Pg-Di-L; 1,2-Propylene Dilaurate; 1,2-Propene Didodecanate; 1,2-Propyleneglycoldilaurate; Dodecanoic Acid, 1-Methyl-1,2-Ethanediyl Ester
- CAS编号22788-19-8
- MFCD编号:MFCD00083068
- EINECS号:245-217-3
- FDA UNII编号:RMY7XGC3LV
- 分子式:C27H52O4分子量:440.71
- 产品CID: 1167082
- 产品分类有机原料→生命科学→生化试剂→脂质
相似化合物
620-67-7 538-24-9 126-53-4物理性质
MSDS等安全信息
上下游产品
CAS号143-07-7 月桂酸 | CAS号57-55-6 丙二醇 | CAS号75-56-9 环氧丙烷 | CAS号112-16-3 十二酰氯 | CAS号645-66-9 月桂酸酐 | CAS号143-07-7 月桂酸 | CAS号10546-44-8 1,2-bis-sulfoox...合成工艺路线路线简述
- 合成目标产物 Propylene Glycol Dilaurate 主要起始原料 Propylene Glycol And Lauric Anhydride
- (文献来源)合成步骤主要原料 Propylene Glycol 和 Lauric Anhydride
📜月桂酸,1,2-丙二醇置于lipase From Humicola Lanuginosa No. 3 Phosphate Buffer体系中,用 水 用作溶剂,化学反应 18.0H,以18.4%的收率获得丙二醇二月桂酸酯
参考文献:Omar,Ibrahim Che; Nishio,Naomichi; Nagai,Shiro,Agricultural And Biological Chemistry,1987,Vol. 51,# 8,P. 2153-2160
标题:Omar,Ibrahim Che; Nishio,Naomichi; Nagai,Shiro,Agricultural And Biological Chemistry,1987,Vol. 51,# 8,P. 2153-2160
海关参考信息
- 2905122000-异丙醇
2905130000-正丁醇
2905310000-1,2-乙二醇
2905320000-1,2-丙二醇 - 💡 提示：海关信息按照顺序优先匹配，如需确认的海关信息，请参考相关资料。
- 详情请参考：📖 海关编码查询和海关进出口税则
专利信息
专利号:US-5902603-A
优先权日:1995-09-14
标题 :Polyurethane hydrogel drug reservoirs for use in transdermal drug delivery systems, and associated methods of manufacture and use
发明人：CHEN TUNG-FEN; CHIANG CHIA-MING; JONA JANAN; JOSHI PRITI; RAMDAS ASHA
权利人:CYGNUS THERAPEUTIC SYSTEMS
摘要:High capacity drug reservoirs are provided for incorporation into transdermal drug delivery systems. The drug reservoirs are hydrogels formulated from polyurethanes crosslinked with diisocyanate crosslinking agents or cured with radiation in the presence of a photoinitator. Drug loading as high as 65 to 70 wt. % or higher can be achieved by absorbing drug formulation into the reservoir after hydrogel synthesis. Methods for making and using transdermal systems containing such reservoirs are provided as well.
专利号:EP-0907359-B1
优先权日:1995-09-14
标 题 :Polyurethane hydrogel drug reservoirs for use in transdermal drug delivery systems
发明人：CHEN TUNG-FEN; CHIANG CHIA-MING; JONA JANAN; JOSHI PRITI; RAMDAS ASHA
权利人:ORTHO MCNEIL PHARM INC
摘要:High capacity drug reservoirs are provided for incorporation into transdermal drug delivery systems. The drug reservoirs are hydrogels formulated from polyurethanes crosslinked with diisocyanate crosslinking agents or cured with radiation in the presence of a photoinitiator. Drug loading as high as 65 to 70 wt.% or higher can be achieved by absorbing drug formulation into the reservoir after hydrogel synthesis. Methods for making and using transdermal systems containing such reservoirs are provided as well.
供应商参考报价(招募中)
品牌试剂参考报价(招募中)
📌 第三方产品分析报告
合成参考文献
摘要:S13 | EUCOSMETICS | Combined Inventory of Ingredients Employed in Cosmetic Products (2000) and Revised Inventory (2006) | DOI:10.5281/zenodo.2624118
摘要:Final Report 12/2014 Available from CIR
摘要:International Journal of Toxicology 18(S2):35-52, 1999
📝 需求与反馈
尽可能描述清楚需求与问题信息
